Cervical Cancer

Cervical cancer, also known as cervical carcinoma, is one of the most common malignant tumor diseases in women worldwide. The cervix, medically also referred to as the cervix uteri, is the lowest part of the uterus that connects the uterus to the vagina. This cancer typically develops from the cells of the mucous membrane lining the cervix and often evolves over several years from so-called precursor stages. Due to its malignant growth and tumor behavior, cervical cancer is classified as a carcinoma. This form of cell growth can also be described as dysplastic cell changes.
Cervical carcinoma is frequently triggered by infection with certain types of human papillomavirus (HPV). These viruses are typically transmitted through sexual contact and can lead to genetic changes in cells over several years, which can eventually develop into tumors.
What is Cervical Cancer?
Cervical carcinoma is a malignant tumor disease that affects the cervix. The cervix is the connection between the uterus and vagina. The lowest part of the cervix, called the cervical os, plays an important role in reproduction, as it opens during childbirth and enables the passage of the baby. At the same time, the cervix can protect the uterus from infections.
Cervical cancer develops in most cases through persistent infection with human papillomaviruses (HPV). Most cases of cervical cancer are caused by HPV infection, particularly by high-risk types HPV 16 and 18, which are responsible for about 70% of cases. These viruses cause genetic changes in cervical cells, which can lead to dysplasia of the mucosal cells. Dysplasias are precursors of cancer, where cells initially grow abnormally and change. If left untreated, these precursor stages can develop into a malignant tumor over several years.
In most cases, the immune system eliminates HPV infection within one to two years. However, if the infection persists, cell changes can occur that may develop into cervical cancer over years. Therefore, HPV vaccination is an important preventive measure to reduce the risk of such infection and thus the likelihood of developing cervical cancer.
Stages and Classification of Cervical Cancer
The classification and staging of cervical cancer are essential for determining appropriate therapy and assessing prognosis. The stages describe the size of the tumor and how far the cancer has spread, based on a systematic examination of the tumor. The classification of different stages of cervical cancer follows the FIGO classification (Fédération Internationale de Gynécologie et d’Obstétrique).
- Stage 0: In this early stage, cancer cells are usually confined to the uppermost cell layer of the cervix and have not spread to deeper tissue or other areas of the body
- Stage I: The tumor is confined to the cervix only. There is no spread to adjacent organs or lymph nodes
- Stage II: The cancer has spread beyond the cervix but has not reached the pelvic wall or the lower portion of the vagina
- Stage III: The tumor has reached neighboring structures such as the pelvic wall, lymph nodes, or lower sections of the vagina. Therefore, cervical cancer stage 3 can lead to symptoms such as bleeding, pain, or urinary tract problems
- Stage IV: This is the most advanced stage, where the cancer has spread to distant organs such as the bladder, intestines, lungs, or liver. Cervical cancer stage 4 is often associated with severe symptoms such as intense pain and organ dysfunction
Precursors of Cervical Cancer
The precursors of cervical cancer, also known as cervical intraepithelial neoplasia (CIN), describe changes in the cells of the cervix. These are usually not yet malignant, but there may be a risk for the development of carcinoma. These precursors are divided into three grades: CIN 1, CIN 2, and CIN 3. These stages depend on the severity of cellular changes.
CIN 1 involves only mild cell changes that often resolve spontaneously. CIN 2 and CIN 3 are considered higher-grade changes with an increased risk of developing into invasive carcinoma. These changes can in most cases be triggered by infection with human papillomaviruses (HPV).
Therefore, regular preventive examinations, such as the Pap test, are of great importance as they enable early detection and treatment of these precursor stages.
Alternative version maintaining same information but slightly more clinical:
Risk Factors and Causes of Cervical Cancer
The development of cervical cancer can be attributed to a combination of various causes and risk factors, with human papillomavirus (HPV) infection being the primary cause. These sexually transmitted viruses, particularly high-risk types such as HPV-16 and HPV-18, can cause cellular changes in the cervix that may develop into carcinoma. The significance of HPV is particularly evident in prevention, as HPV vaccination protects both women and men against certain virus types and reduces the risk of transmitting the virus, which emphasizes its importance for men as well. Studies have shown that vaccination could prevent up to 99% of HPV infections and almost all cervical precursor lesions, provided there was no prior HPV infection at the time of vaccination.
Besides HPV, there are other risk factors:
- Smoking: The harmful substances in tobacco weaken the immune system and promote cellular damage that can contribute to cancer development.
- Weakened Immune System: Conditions such as HIV or the use of immunosuppressive medications reduce the body's ability to fight HPV infections.
- Family History: A genetic predisposition can also increase the risk of cervical cancer.
- Sexually Transmitted Diseases: Infections such as chlamydia or herpes simplex promote chronic inflammation and thus increase the risk of cellular changes.
- Unprotected Sexual Intercourse: A high number of sexual partners or unprotected sexual intercourse significantly increases the probability of HPV infection. Men play the role of transmitters, which highlights the importance of HPV vaccination for both genders.
HPV and Cervical Cancer
The connection between human papillomaviruses (HPV) and cervical cancer is scientifically well-established. Human papillomaviruses are a group of viruses, of which certain high-risk types such as HPV-16 and HPV-18 are responsible for the majority of cervical cancer cases. These viruses can be transmitted through sexual contact and, when infection occurs, lead to changes in cervical cells. If the infection is not eliminated by the immune system, these cellular changes can develop into precursor stages and eventually into carcinoma.
The HPV vaccination provides effective protection against the most common high-risk types associated with cervical cancer. The vaccine stimulates the production of antibodies against these virus types. This prevents the spread of infection before it can cause damage to the cervix. The vaccination is recommended not only for young women but also for men, as this can reduce the risk of virus transmission and thus make an important contribution to prevention.
Cervical Cancer Symptoms and Signs
The symptoms of cervical cancer (cervical carcinoma) often appear only in more advanced stages, which is why regular preventive examinations are crucial for early detection of infection. The most common and important signs that could indicate a possible illness include:
- Irregular bleeding: particularly breakthrough bleeding or bleeding after sexual intercourse
- Unusual discharge, often with changed odor or bloody
- Irregular menstrual bleeding
- Pain in the lower abdomen or lower back
- Unexplained weight loss
- Chronic fatigue or general weakness
These symptoms don’t always occur regularly and can also be caused by other conditions. Nevertheless, it is extremely important to have them medically evaluated to rule out cervical cancer infection and avoid possible long-term consequences.
Early Detection and Diagnosis
Early detection of cervical cancer is crucial to discover the disease in an early and, most importantly, treatable stage. Regular preventive examinations make it possible to identify cell changes in the cervix early, before they can develop into carcinoma.
Studies show that of 1000 women who regularly participate in early detection screenings, less than one develops cervical cancer in their lifetime and can thus avoid carcinogenesis. In contrast, of 1000 women who did not participate in these examinations, about 30 developed cervical cancer during their lifetime.
These numbers demonstrate the effectiveness of early detection, as regular preventive examinations can significantly reduce the risk of developing cervical cancer. Therefore, it is important to attend preliminary examinations to detect and treat possible cell changes early.
Cervical Cancer Prevention
Preventive examination plays a significant role in early detection and particularly prevention of cervical cancer. Through regular check-ups, suspicious cell changes can be detected and treated in time before they can develop into a malignant tumor. Cervical cancer screening is regularly offered in many countries and is an important part of healthcare for women from a certain age. It is conducted at regular intervals.
Classical preventive examinations include the so-called Pap test (Papanicolaou test). In this test, a cell sample is taken from the cervix, for example with a small brush, and examined for suspicious changes or infections. The test primarily serves to identify dysplasias, which are generally considered precursors of cervical cancer.
Additionally, in many countries, HPV screening is also offered as a preventive procedure. Here, the sample is specifically tested for human papillomaviruses (HPV), particularly the high-risk types HPV-16 and HPV-18, which are directly linked to the development of cervical cancer.
These two examination methods complement each other and thus provide high reliability in the early detection of cervical diseases.
Cervical Cancer Diagnosis
The diagnosis of cervical cancer is based on various medical procedures, each aimed at detecting possible signs of cancer or early cellular changes. The most important methods besides physical examination include:
- Pap Smear: During the Pap test, a smear of cells from the cervix is carefully taken to detect changes or abnormalities in the cells. This is one of the most commonly performed tests for early detection of cervical cancer and enables the identification of precancerous changes, known as dysplasias.
- Biopsy: If the Pap smear shows certain abnormalities, a biopsy may be performed. In this procedure, a small piece of tissue is taken from the cervix and examined more closely in the laboratory for malignant cells. The biopsy allows for a significantly more accurate determination of cellular changes and thus a specific diagnosis.
- HPV Test: An HPV test specifically checks for the presence of human papillomavirus (HPV) infection, which is associated with a significantly increased risk of cervical cancer. This test can be performed in combination with the Pap smear to determine if there is an infection with high-risk HPV types.-
- Ultrasound: An ultrasound of the abdominal cavity or pelvic organs can be used to detect possible larger changes in the uterus or surrounding organs. In cases of suspected advanced cervical cancer, ultrasound can help assess the extent of the tumor and rule out possible metastases.
All these methods enable precise diagnosis and are particularly crucial for early detection and timely treatment of cervical cancer.
Treatment of Cervical Cancer
The treatment of cervical cancer can be individualized and depends on several factors, such as the stage of cancer, tumor size, and the patient’s general health condition. The most common treatment methods include surgical procedures, radiation therapy, and chemotherapy, which can also be combined. In early stages, surgery alone might be sufficient, while advanced stages may require a combination of radiation therapy and chemotherapy. It is therefore crucial that treatment is individually tailored to achieve the best results for each patient.
Conventional Medical Treatment Options for Cervical Cancer
Surgical treatment (e.g., conization, hysterectomy)
- Radiation therapy and chemotherapy
- Immunotherapy
- Radiation therapy and chemotherapy
The treatment of cervical cancer is primarily based on the stage of the disease, the patient’s general health condition, and other patient-specific factors. The most common conventional medical approaches include surgical procedures, as well as radiation therapy and chemotherapy. However, newer approaches such as immunotherapy are becoming increasingly prominent.
Surgical treatment is usually the first choice in early stages of cervical cancer. Depending on the progression of the disease, various procedures can be performed, such as conization, where only a portion of the cervix is removed, or in more invasive cases, a hysterectomy, where the entire uterus is removed. The goal of these procedures is to completely remove the tumor and prevent its spread.
In more advanced stages, radiation therapy and chemotherapy are often used, either alone or in combination. Radiation therapy uses targeted radiation of the tumor to destroy cancer cells, while chemotherapy works more systemically and attacks potential metastases. The combined use of these procedures is particularly effective as they work synergistically and can increase chances of cure.
A further promising development in the treatment of cervical cancer is immunotherapy, which aims to activate the body’s own immune system to specifically fight cancer cells. These therapeutic approaches are still in ongoing development and could be particularly significant for patients in later stages or with recurrent cancer.
The choice of the right treatment is thus very individual and depends on many factors. Therefore, close consultation with specialized doctors and a multidisciplinary approach is essential to develop the optimal therapy for each patient.
Complementary Medical Treatment Options for Cervical Cancer
Alongside conventional medical treatment approaches, there is a significant range of complementary medical methods that can be used in conjunction with conventional therapy. These methods aim to increase patient well-being, improve quality of life, and strengthen the immune system, both to support conventional medical therapies and to promote healing more effectively.
Hyperthermia is a method where the body or specific body regions are deliberately heated. In local hyperthermia, only the tumor area is heated, while in whole-body hyperthermia, the entire body is exposed to controlled heat. Through heat application via hyperthermia, cancer cells can be made more sensitive to radiation therapy and chemotherapy, particularly when exposed to significantly higher temperatures. This method can help reduce tumors and specifically enhance the effectiveness of conventional therapies.
Active fever therapy is another approach where controlled fever is initiated and used as a natural defensive reaction of the body to activate the immune system and strengthen the body’s own defenses against tumor cells. It is often used supportively in cancer treatment as it stimulates metabolism and makes nutrient transport more difficult for tumors.
Mistletoe therapy has gained an important role in complementary cancer therapy. Mistletoe preparations are used for their immune-strengthening effects to stimulate the immune system and consequently improve the patient’s quality of life. Through its mechanism of action, mistletoe therapy can thus alleviate side effects of treatments like chemotherapy and promote healing and patient well-being.
Another important complementary medical procedure is acupuncture. By placing fine needles at specific acupuncture points, blockages in the body’s energy flow can be released. In cervical cancer, acupuncture can provide supportive effects by relieving pain, reducing nausea, and increasing general well-being.
Finally, immune strengthening is a central aspect of complementary medical treatment. This includes measures such as micro-immunotherapy, which supports the immune system at the cellular level, and the use of nutritional supplements that can strengthen the body’s natural defenses. These include vitamins, minerals, and herbal preparations that support the immune system naturally.
All these complementary medical procedures can meaningfully supplement and support conventional medical treatment for cervical cancer by stimulating the body’s self-healing powers and improving the patient’s general well-being.
Chances of Recovery and Prognosis for Cervical Cancer
The chances of recovery from cervical cancer depend on various factors, including the stage of the disease, the presence of metastases, and the patient’s general health condition. In early stages, when the tumor is still locally confined, the chances of recovery are usually very good. Thanks to modern diagnostics, preventive examinations, and treatment procedures, up to 90% of patients with early-stage cervical cancer can be successfully treated. However, survival rates decrease with advancing stages of the disease.
The prognosis is significantly influenced by the stage of the disease. While the 5-year survival rate in stage I is over 90%, it drops to about 50% in stage III and significantly below 20% in stage IV when cancer has metastasized. The course of the disease also depends on the aggressiveness of the cancer cells and their response to therapeutic approaches such as chemotherapy or radiation therapy.
Additionally, other accompanying diseases and the patient’s age play a crucial role in life expectancy and choice of therapy. Individual differences in immune response and compliance with follow-up care can also influence the course of the disease.
Cervical Cancer Prevention
Prevention of cervical cancer encompasses several different approaches, including not only medical examinations but also good education and preventive measures. An important aspect is education about the transmission routes of human papillomavirus (HPV), which is a main cause of cervical cancer. Knowledge about HPV is particularly crucial in the context of sexual hygiene.
Men also play a crucial role in prevention, as they often unknowingly transmit the virus. Men’s role as carriers makes it necessary for both genders to be aware of the risks and prevention possibilities. This includes the recommendation of HPV vaccination for men, as this not only protects their own health but also reduces virus transmission and thus can indirectly protect women from infection.
Therefore, it can be said that conscious attention to sexual hygiene, knowledge about protective measures such as condoms, and regular participation in preventive examinations are crucial in limiting the spread of the virus and reducing the long-term incidence rate of cervical cancer.
Conventional Medical Approach - Cervical Cancer Vaccination
Vaccination against cervical cancer, more specifically against human papillomavirus (HPV), represents a central measure in preventing cervical cancer. The HPV vaccination specifically aims to combat high-risk virus types, such as HPV-16 and HPV-18. It is particularly recommended for girls and boys aged 9 to 14 years, as during this period the immune system can respond optimally to the vaccination, and protection against later infection can be ensured before the onset of sexual activity. Depending on the age at vaccination initiation, two to three doses are required.
The effectiveness of the vaccination is well documented. It reliably protects against most HPV-related diseases, including cervical cancer and other HPV-associated cancers. Vaccination for men is also gaining importance as it helps prevent virus transmission during sexual contact.
As with any medical intervention, potential side effects of HPV vaccination should be carefully considered. Although known side effects are generally mild, it is advisable to seek comprehensive consultation with an experienced physician before vaccination. The doctor can assess individual risk factors and possible contraindications, enabling an informed decision for or against vaccination. Such clarification is particularly important for people with pre-existing conditions or known allergies.
Complementary Medical Approach to Prevention
In the comprehensive view of health prevention, particularly for cervical cancer prevention, complementary medical approaches are gaining increasing importance. These methods aim to strengthen the immune system and support the body’s natural defense functions.
Gut health is an important aspect. A healthy gut microbiome contributes significantly to strengthening the immune system. Taking probiotics can help optimize gut flora and thus improve the body’s natural defenses.
Orthomolecular medicine focuses on the targeted intake of micronutrients. Vitamin A, Vitamin C, and Vitamin D, as well as zinc and omega-3 fatty acids, play important roles in supporting the immune system. These nutrients can be obtained through both diet and supplements.
Phytotherapy utilizes the healing power of plants. Certain herbs and plant extracts can have immunomodulating and antiviral properties that may be helpful in preventing viral infections.
A relatively new approach is micro-immunotherapy, which aims to regulate and strengthen the immune system through the administration of low-dose immune messenger substances.
A healthy, balanced diet rich in fruits, vegetables, and high-fiber foods forms the foundation for a strong immune system. It provides important nutrients and antioxidants that support the body in fighting pathogens.
Stress reduction also plays an important role. Chronic stress can weaken the immune system. Relaxation techniques such as meditation, yoga, or regular exercise can help reduce stress and strengthen the body’s natural defenses.
It’s important to emphasize that these complementary approaches should not replace conventional medical prevention, including regular check-ups, but rather supplement them. Consultation with a doctor should always be sought before application to rule out possible interactions or contraindications. An integrative approach that considers both conventional and complementary methods can contribute to comprehensive health prevention.
Sources:
-
- Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis
- Dose-risk relationships between cigarette smoking and cervical cancer: a systematic review and meta-analysis
- Chlamydia Infection as a Risk Factor for Cervical Cancer: A Systematic Review and Meta-Analysis
- Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective Get access Arrow
- HPV – humane Papillomaviren
- Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials
- Advances in immunotherapy in cervical cancer
- Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?
- Hyperthermia in combined treatment of cancer
- Hyperthermia in cancer treatment
- Mistletoe treatments for minimising side effects of anticancer chemotherapy
- Safety of acupuncture in oncology: A systematic review and meta-analysis of randomized controlled trials
- Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis
Med. pract. Dana Hreus M.A.
An integrative approach with complementary measures can improve the success of therapy and reduce the side effects of conventional cervical cancer treatment.

Frequently Asked Questions about Cervical Cancer
In the following section, we will address your most common questions to help you better understand cervical cancer in terms of its development, symptoms, and treatment:
Cervical cancer often causes no noticeable symptoms in early stages and is therefore usually discovered during preventive examinations. However, in more advanced stages, symptoms such as unusual bleeding, changed discharge, or pain in the lower abdomen may occur, which should definitely be medically evaluated.
Yes, cervical cancer is generally curable, especially when detected at an early stage. However, the chances of cure depend on the stage of the disease, its spread, and the chosen treatment method. Therefore, regular preventive examinations and early therapy play a central role in the prospects of success.
The procedure for a preventive examination for early detection of cervical cancer usually consists of a Pap smear, where cells are taken from the cervix to check for possible cell changes. In some cases, an additional HPV test is performed to determine if there is an infection with human papillomaviruses (HPV), which can increase the risk of cervical cancer. The examination is usually painless and takes only a few minutes.
Cervical cancer itself cannot be transmitted directly from person to person, however, the development of the disease is often caused by persistent infection with certain types of human papillomaviruses (HPV). These viruses are mainly transmitted through sexual contact. Therefore, the risk of developing cervical cancer is higher if an HPV infection persists over an extended period.
Experience reports from affected individuals regarding cervical cancer symptoms vary, as the disease often causes no noticeable symptoms in its early stages. Some women report irregular bleeding or unusual discharge, which they initially attributed to other causes. In later stages, increased pain in the lower abdomen or bleeding after intercourse may occur. Many affected individuals share their experiences in forums, helping other women become aware of possible symptoms. However, it is important not to ignore symptoms and to seek early medical evaluation, as cervical cancer is often treatable in early stages.
In the terminal stage of cervical cancer, symptoms can be significantly more intense and diverse. Common signs include severe and persistent pain in the lower abdomen or pelvic area, which may also radiate to surrounding organs. Bleeding, which is often difficult to control, particularly after intercourse or outside of menstruation, is also typical. In advanced cases, there may also be unintentional weight loss, fatigue, and loss of appetite. Other symptoms in the terminal stage include changes in urination or bowel movements, which can be caused by metastases to neighboring organs, as well as a general deterioration of overall health. However, symptoms vary individually and depend on the spread of the tumor.
With cervical cancer, menstrual bleeding can vary. In early stages, irregular or heavier bleeding during menstruation may occur. In advanced stages, there may also be intermenstrual bleeding, meaning bleeding outside of normal periods. Spotting after intercourse is also common. In some cases, persistent or unusually heavy bleeding may occur, which can be interpreted as a sign of advanced disease. It is important to seek medical examination for any changes in bleeding rhythm or pattern, as this may indicate a possible illness.
Cervical cancer is primarily caused by infection with specific types of human papillomavirus (HPV), particularly high-risk types HPV 16 and 18. These viruses are transmitted through sexual contact and cause changes in the cells of the cervix. Over time, these cellular changes, known as dysplasia, can develop into cervical cancer. It’s crucial to understand that not every HPV infection leads to cervical cancer; the immune system successfully fights off many infections. However, a persistent infection that isn’t eliminated by the body over years can increase the risk of developing cervical cancer.
Yes, men can also be vaccinated against Human Papillomavirus (HPV). The HPV vaccination isn’t just used to prevent cervical cancer in women, but also to reduce the risk of other HPV-associated cancers in men. The vaccine protects against high-risk HPV types responsible for these cancers. Furthermore, it reduces the likelihood of transmitting the virus to others. For this reason, HPV vaccination is recommended for boys and young men in many countries.
The HPV vaccination typically consists of two or three doses, depending on the age of the person being vaccinated and the vaccine used. When vaccination occurs before the 15th birthday, usually only two doses are required, administered six to twelve months apart. For individuals vaccinated after age 15, three doses are necessary, administered over a period of six months. It’s essential to receive all recommended doses of the vaccine to ensure complete protection against the most common HPV types associated with cervical cancer.
Video about Cancer
Further information
The information listed contains relevant topics and serves to improve understanding.